151 related articles for article (PubMed ID: 8473265)
1. TGF-beta gene expression depends on tissue architecture.
Theodorescu D; Sheehan C; Kerbel RS
In Vitro Cell Dev Biol; 1993 Feb; 29A(2):105-8. PubMed ID: 8473265
[No Abstract] [Full Text] [Related]
2. Transforming growth factor-beta negatively modulates proliferation and c-fos expression of the human endometrial adenocarcinoma cell line HEC-1-A.
Bergman CA; Talavera F; Christman GM; Baker VV; Roberts JA; Menon KM
Gynecol Oncol; 1997 Apr; 65(1):63-8. PubMed ID: 9103392
[TBL] [Abstract][Full Text] [Related]
3. Early gene responses associated with transforming growth factor-beta 1 growth inhibition and autoinduction in MCF-7 breast adenocarcinoma cells.
Lafon C; Mazars P; Guerrin M; Barboule N; Charcosset JY; Valette A
Biochim Biophys Acta; 1995 May; 1266(3):288-95. PubMed ID: 7766715
[TBL] [Abstract][Full Text] [Related]
4. Alteration of cell growth and morphology by overexpression of transforming growth factor beta type II receptor in human lung adenocarcinoma cells.
Kim TK; Mo EK; Yoo CG; Lee CT; Han SK; Shim YS; Kim YW
Lung Cancer; 2001; 31(2-3):181-91. PubMed ID: 11165397
[TBL] [Abstract][Full Text] [Related]
5. Differential induction of early response genes by adrenomedullin and transforming growth factor-beta1 in human lung cancer cells.
Kane S; Prentice MA; Mariano JM; Cuttitta F; Jakowlew SB
Anticancer Res; 2002; 22(3):1433-44. PubMed ID: 12168820
[TBL] [Abstract][Full Text] [Related]
6. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.
Tobin SW; Douville K; Benbow U; Brinckerhoff CE; Memoli VA; Arrick BA
Oncogene; 2002 Jan; 21(1):108-18. PubMed ID: 11791181
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor (TGF)-beta stimulates hepatic jun-B and fos-B proto-oncogenes and decreases albumin mRNA.
Beauchamp RD; Sheng HM; Ishizuka J; Townsend CM; Thompson JC
Ann Surg; 1992 Sep; 216(3):300-7; discussion 307-8. PubMed ID: 1417179
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor beta 1-induced apoptosis in human ovarian carcinoma cells: protection by the antioxidant N-acetylcysteine and bcl-2.
Lafon C; Mathieu C; Guerrin M; Pierre O; Vidal S; Valette A
Cell Growth Differ; 1996 Aug; 7(8):1095-104. PubMed ID: 8853906
[TBL] [Abstract][Full Text] [Related]
9. A kinase-defective transforming growth factor-beta receptor type II is a dominant-negative regulator for human breast carcinoma MCF-7 cells.
Ko Y; Koli KM; Banerji SS; Li W; Zborowska E; Willson JK; Brattain MG; Arteaga CL
Int J Oncol; 1998 Jan; 12(1):87-94. PubMed ID: 9454891
[TBL] [Abstract][Full Text] [Related]
10. TGF-beta stimulation of endometrial and breast-cancer cell growth.
Croxtall JD; Jamil A; Ayub M; Colletta AA; White JO
Int J Cancer; 1992 Mar; 50(5):822-7. PubMed ID: 1312067
[TBL] [Abstract][Full Text] [Related]
11. Effects of TGF-β signaling blockade on human A549 lung adenocarcinoma cell lines.
Xu CC; Wu LM; Sun W; Zhang N; Chen WS; Fu XN
Mol Med Rep; 2011; 4(5):1007-15. PubMed ID: 21725601
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.
Venkatasubbarao K; Ahmed MM; Mohiuddin M; Swiderski C; Lee E; Gower WR; Salhab KF; McGrath P; Strodel W; Freeman JW
Anticancer Res; 2000; 20(1A):43-51. PubMed ID: 10769633
[TBL] [Abstract][Full Text] [Related]
13. Effects of TGF-beta 1 (transforming growth factor-beta 1) on the cell cycle regulation of human breast adenocarcinoma (MCF-7) cells.
Mazars P; Barboule N; Baldin V; Vidal S; Ducommun B; Valette A
FEBS Lett; 1995 Apr; 362(3):295-300. PubMed ID: 7729516
[TBL] [Abstract][Full Text] [Related]
14. Regulation of c-fos and c-jun expression by calcitonin in human breast cancer cells.
Lacroix M; Body JJ
Calcif Tissue Int; 1997 Jun; 60(6):513-9. PubMed ID: 9164825
[TBL] [Abstract][Full Text] [Related]
15. Characterization of mutated transforming growth factor-beta s which possess unique biological properties.
Qian SW; Burmester JK; Sun PD; Huang A; Ohlsen DJ; Suardet L; Flanders KC; Davies D; Roberts AB; Sporn MB
Biochemistry; 1994 Oct; 33(40):12298-304. PubMed ID: 7918451
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the levels of three transforming growth factor beta mRNAs by estrogen and their effects on the proliferation of human breast cancer cells.
Jeng MH; ten Dijke P; Iwata KK; Jordan VC
Mol Cell Endocrinol; 1993 Nov; 97(1-2):115-23. PubMed ID: 8143893
[TBL] [Abstract][Full Text] [Related]
17. Induction of transforming growth factor beta 1 and its receptors during all-trans-retinoic acid (RA) treatment of RA-responsive human neuroblastoma cell lines.
Cohen PS; Letterio JJ; Gaetano C; Chan J; Matsumoto K; Sporn MB; Thiele CJ
Cancer Res; 1995 Jun; 55(11):2380-6. PubMed ID: 7757990
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a human hepatoma cell line with acquired resistance to growth inhibition by transforming growth factor beta 1 (TGF-beta 1).
Hasegawa K; Wang Z; Inagaki M; Carr BI
In Vitro Cell Dev Biol Anim; 1995 Jan; 31(1):55-61. PubMed ID: 7704334
[TBL] [Abstract][Full Text] [Related]
19. Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.
Herman ME; Katzenellenbogen BS
Cancer Res; 1994 Nov; 54(22):5867-74. PubMed ID: 7954416
[TBL] [Abstract][Full Text] [Related]
20. Differential effect of genistein on transforming growth factor beta 1 expression in normal and malignant mammary epithelial cells.
Sathyamoorthy N; Gilsdorf JS; Wang TT
Anticancer Res; 1998; 18(4A):2449-53. PubMed ID: 9703891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
